Assessing the severity of inflammatory activity in RA patients has long remained a challenging topic.[42] A phenomenon exists here that in patients with low disease activity, indicators such as ESR, CRP, and RF are often at critical thresholds and can easily be overlooked. The gene discussed is ESR1; the disease is rheumatoid arthritis.